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Abstract
Sepsis causes microvascular dysfunction. Increased heterogeneity
of capillary blood flow results in local tissue hypoxia, which can
cause local tissue inflammation, impaired oxygen extraction, and,
ultimately, organ dysfunction. Microvascular dysfunction is clinically
relevant because it is a marker for mortality: it improves rapidly in
survivors of sepsis but fails to improve in nonsurvivors. This, along
with the fact that resuscitation of mean arterial pressure and
cardiac output alone fails to improve microvascular function, means
that microvascular resuscitation is therefore a therapeutic goal. In
animal studies of sepsis, volume resuscitation improves micro-
vascular permeability and tissue oxygenation, and leads to
improved organ function, including a reduction in myocardial dys-
function. Microvascular resuscitation strategies include hemodynamic
resuscitation using the linked combination of volume resuscitation,
judicious vasopressor use, and inotropes and vasodilators.
Alternative vasoactive agents, such as vasopressin, may improve
microcirculatory function to a greater degree than conventional
vasopressors. Successful modulation of inflammation has a
positive impact on endothelial function. Finally, targeted treatment
of the endothelium, using activated protein C, also improves
microvascular function and ultimately increases survival. Thus,
attention must be paid to the microcirculation in patients with
sepsis, and therapeutic strategies should be employed to
resuscitate the microcirculation in order to avoid organ dysfunction
and to reduce mortality.
Introduction
Impaired microvascular function is increasingly recognized as
a key characteristic contributing to organ dysfunction and
death in patients with sepsis. In fact, impaired oxygen
extraction in patients who have sepsis was recognized more
than 40 years ago, although it is only more recently that there
has been consensus among investigators that microvascular
dysfunction is a central feature of sepsis, accounting for many
characteristics of the pathogenesis of septic organ
dysfunction [1-5]. Indeed, a key observation is that thera-
peutic modalities that may improve microvascular function are
also associated with decreased organ dysfunction and
improved outcome in patients with sepsis [6-8]. Furthermore,
since normal endothelial function underlies normal micro-
vascular function, there is an increasing interest in endothelial
function during sepsis [9-12]. It is therefore vital to
understand as much as possible about the microcirculation
and endothelium in sepsis in order to identify therapeutic
strategies for resuscitating the microcirculation and thus
improving outcome.
Microvascular dysfunction in sepsis
The clinical observations of cyanosis with mottled skin, and
evidence of tissue hypoxia (e.g. elevated lactate levels)
despite high cardiac output, are common and long-
recognized in patients with septic shock. Taken together with
reports of abnormal sublingual perfusion in septic patients
[13-15], these simple observations suggest that micro-
vascular dysfunction occurs and leads to impaired tissue
oxygen transport. Recently, microvascular function has been
examined more vigorously in experimental models of sepsis
where increased heterogeneity of microvascular perfusion is
a hallmark of sepsis. Ellis and colleagues [16,17] demon-
strated that microvascular dysfunction occurs in the skeletal
muscle microcirculation in septic rats following cecal ligation
and puncture. In this rat model, the authors reported an
increase in stopped-flow capillaries that was consistent with
other reports [18], as well as an increase in the proportion of
fast-flow to normal-flow capillaries and a decrease in capillary
venular-end erythrocyte hemoglobin oxygen saturation levels,
while capillary arteriolar-end erythrocyte hemoglobin oxygen
saturation remained unchanged. Capillary oxygen extraction
was found to increase threefold and be directly related to the
degree of stopped flow. The authors concluded that the
septic microcirculation could no longer regulate flow to
regions of higher oxygen demand.
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Similarly, animal models of sepsis have shown the existence
of a greater number of adherent neutrophils in the coronary
microcirculation [19,20], which is associated with increased
heterogeneity in blood flow and impaired myocardial oxygen
extraction [21]. Such observations in animal models are
consistent with clinical observations of impaired oxygen
extraction in human sepsis [22,23]. Microvascular dys-
function leading to impaired tissue oxygen extraction [24-26]
has also been observed by several groups in the gut of animal
sepsis models [3,24,27]. Increased heterogeneity of capillary
blood flow, as measured by reduced capillary density, is a
uniform link relating microvascular dysfunction to impaired
oxygen extraction [24,26,28,29].
In a theoretical study, increased heterogeneity of capillary-
bed blood flow was predicted to lead to regions of tissue
hypoxia, and to a generally decreased ability of tissues to
extract oxygen [24,26,28,29]. In this model, if some capillary
beds have increased blood flow beyond their metabolic
demand, while other capillary beds have reduced blood flow
below their metabolic demand, then, when blood flow is
limited, the onset of anaerobic metabolism in a substantial
fraction of the involved tissue bed will occur early. The critical
oxygen extraction ratio is, therefore, decreased in the setting
of increased heterogeneity of microvascular blood flow.
Humer and colleagues directly tested this theory in the
porcine gut using an endotoxemic model of sepsis [24]. They
showed that the increased heterogeneity of blood flow that
occurs in a large-animal model of sepsis matched the predicted
critical oxygen extraction ratio derived from the theoretical
analysis. This suggests that microvascular dysfunction from
sepsis leads to impaired extraction of tissue oxygen.
Microvascular dysfunction in humans
Clinically, microvascular dysfunction is seen in patients by
using polarized light microscopy to examine sublingual micro-
vessels. Using this technique, De Backer and colleagues
have observed increased heterogeneity in microvascular
blood flow in patients with septic shock [15]. Those patients
who survived demonstrated improved microvascular function
during the first few days of hospitalization, while no improve-
ment in microvascular dysfunction was seen with time in non-
survivors [13]. In essence, microvascular dysfunction occurs
during sepsis and leads to impaired tissue oxygen extraction,
causing heterogeneous tissue hypoxia that is spatially
correlated with tissue inflammation. These observations are
associated with an adverse clinical outcome.
Changes in endothelial cell signaling and function
Alterations in endothelial cell function underlie impaired
microvascular blood flow (Fig. 1). Activation of the endo-
thelium by circulating inflammatory cytokines leads to
increased expression of endothelial adhesion molecules,
including rapid expression of P-selectin and, later, an
increase in expression of intercellular adhesion molecule-1
(ICAM-1) and vascular cell adhesion molecule-1 over several
hours. Similarly, activated leukocytes increase their
adherence to the endothelium by upregulating expression of
cognate integrin receptors. In small vessels, leukocyte
adhesion may contribute to disordered microvascular flow
and potentially increase the inflammatory response within
these local capillary beds by mediating the release of
proinflammatory cytokines, reactive oxygen species,
proteases and other inflammatory mediators.
Tyml and colleagues have identified disordered endothelial
signaling function as an underlying mechanism leading to
reduced microvascular regulation [30,31]. They describe
how, in health, the endothelium produces signals upstream
via tight junctions to precapillary arterioles so as to regulate
blood flow to maintain homogeneity in normally functioning
capillary beds. In models of sepsis, the authors showed that
endothelial signaling is disrupted and leads to the impairment
of precapillary arteriolar regulation.
Activation of this damaged endothelium produces an
increased expression of adhesion molecules. This also leads
to increased production of nitric oxide and impairment of the
inflammation-related clotting system, including alterations in
the expression of thrombomodulin and endothelial protein C
receptor, and altered signaling via proteinase-activated
receptor-1 and other pathways.
Tissue-based inflammation and resultant organ
dysfunction
The capillary-endothelium-based inflammatory response,
which is activated in sepsis, results in the generation of a
systemic inflammatory response involving parenchymal cells
in a variety of organ systems. In the heart, for example,
cardiac myocytes release chemotactic cytokines. Then,
fibrinogen extravasates into the extracellular space, which
triggers cardiac myocytes to increase their expression of
ICAM-1 so that the myocardium actively participates in
directing an intraparenchymal inflammatory response. The
parenchymal and capillary-endothelium-based inflammatory
responses lead to impaired organ function.
In the heart in sepsis, evidence of tissue hypoxia includes
increased release of troponin. However, the appearance of
regional abnormalities on echocardiographic examination in
sepsis is not typical of occlusion of single major coronary
arteries. Echocardiographic examination may disclose small
regions of impaired function, resulting in an overall decrease
in ejection fraction. This paradigm for impaired organ function
in sepsis is also demonstrated by other organs, including the
brain, the kidneys and the gut.
Therapeutic goals
Resuscitation of mean arterial pressure and cardiac
output alone is not enough
As a therapeutic strategy, resuscitation of mean arterial
pressure (MAP) and cardiac output alone is not enough toS29
resuscitate the microcirculation. Several pieces of evidence
support this conclusion. An important study by LeDoux and
colleagues [32] examined various hemodynamic parameters,
as well as measures of tissue oxygenation, in patients treated
with norepinephrine for septic shock. The investigators
titrated the norepinephrine infusion to maintain a MAP of
65 mmHg, followed by 75 mmHg and then 85 mmHg. This
combined  α- and β-agonist led to increases in heart rate,
MAP (by experimental design), and cardiac index (P < 0.07).
The end result was a substantial increase in left ventricular
stroke work index and a trend towards an increasing systemic
vascular resistance index. Thus, from a purely hemodynamic
perspective, norepinephrine appeared to be clinically
beneficial. However, when the investigators looked for
evidence of changes in organ function and adequate tissue
oxygenation, the results were strikingly different: urine output
decreased, capillary blood flow showed a trend to decreasing
values, and capillary red blood cell velocity did not change.
Furthermore, intramucosal partial pressure of carbon dioxide,
measured using a gastric tonometer, and the gradient of
pressure difference between arterial oxygen and inspired
carbon dioxide both increased, indicating potentially impaired
tissue oxygenation. Together, these results are evidence in
human septic shock that resuscitation of MAP and cardiac
output alone is inadequate.
Organ function improves when the microcirculation is
also resuscitated
There is increasing evidence to show that organ function
improves and mortality decreases when resuscitation boosts
microcirculatory flow. Spronk and colleagues [14] demon-
strated that the marked microvascular heterogeneity and
dysfunction in patients with sepsis can be improved
dramatically after a nitroglycerin infusion.
Microvascular function can, in animal models, be ameliorated
by an adequate level of volume resuscitation. For example,
volume resuscitation has been shown in studies by Anning
and colleagues to decrease microvascular permeability in
animal models of sepsis [33]. The same group demonstrated
that, when microvascular function is improved by volume
resuscitation in this way, tissue oxygenation improves [34]. In
healthy animals, an increase in the fraction of inspired oxygen
(FiO2) results in an expected increase in tissue oxygenation,
while in endotoxemic animals the same increase in FiO2 has
no effect on tissue oxygenation [34]. However, when
endotoxemic animals were volume-resuscitated, an increase
in FiO2 resulted in an increase in tissue oxygenation.
Further animal studies of volume resuscitation have
demonstrated that organ function is also improved [35]. A
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Figure 1
Multiphoton images of CD1 mouse hind-limb extensor digitorum longus (EDL) skeletal muscle microcirculation. After blunt dissection of the EDL,
mice were injected with fluorescent nanoparticles via the tail vein. Images were acquired by exciting tissue at 900 nm using a titanium sapphire
laser and collecting the fluorescent signal using a Leica SP2 microscope (Lecia, Richmond Hill, Ontario, Canada). Images were pseudo colored for
depth: brown represents the surface, green 75 µm depth and blue 150 µm depth. (a) The normal homogeneous appearance in control mice is
disrupted (b) in mice 5 hours after endotoxin-treatment. Solid lines indicate perfused capillaries, whereas broken lines indicate stopped capillary
flow.S30
series of studies has shown that cardiomyocyte contractility
is decreased 5 hours after an endotoxin injection in rats [35].
However, when these rats are volume-resuscitated, cardio-
myocyte function is improved. In these studies, albumin
resuscitation appeared to be superior to saline resuscitation.
Part of the improvement in myocardial function with albumin
resuscitation appears to be related to a decrease in inducible
nitric oxide synthase mRNA and protein expression in
albumin-treated animals compared with other volume-
resuscitated groups.
Strategies for resuscitating the
microcirculation in septic patients
Combinational hemodynamic strategies
A number of strategies have emerged for resuscitating the
microcirculation in septic patients. While vasopressor therapy
alone is insufficient for resuscitation, it is now clear that the
combination of adequate volume resuscitation, use of a
vasopressor to maintain a reasonable MAP, and additional
use of blood transfusion, inotropes or vasodilators to ensure
adequate global oxygen delivery, is effective. This hemo-
dynamic combinational strategy improves microcirculatory
flow and organ function, and, ultimately, improves survival.
Rivers and colleagues developed a protocol for this treatment
in their “early goal-directed therapy” study [8]. They
demonstrated that a combination of volume resuscitation to
achieve a central venous pressure of 8–12 mmHg, addition of
a vasopressor agent to maintain MAP >65 mmHg, measure-
ment of central venous oxygen saturation, and use of
transfused red blood cells and/or inotropic agents to increase
central venous oxygen saturation to >70% brought about a
substantially reduced mortality rate in patients with septic
shock (30.5% for early goal-directed therapy versus 46.5%
for standard therapy; P = 0.009).
Vasoactive agents
In addition, alternative vasoactive agents should be
considered. For example, in an early randomized controlled
trial of vasopressin, Patel and colleagues found that equally
hypertensive doses of norepinephrine and vasopressin
maintained cardiac output to the same extent, yet urine
output and creatinine clearance were increased in the vaso-
pressin-treated group [36]. Previous studies in rats have
demonstrated that vasopressin differs from norepinephrine in
its effects on the microcirculation [37]. The afferent
glomerular arterioles constrict more readily when exposed to
norepinephrine than vasopressin, whereas the efferent
glomerular arterioles constrict more readily when exposed to
vasopressin than norepinephrine [37]. An increased
glomerular perfusion pressure and increased urine output is
the result. This demonstrates how different vasopressor
agents affect the microcirculation to a varying degree. Further
studies are required to determine which vasopressor
strategies should best be used to treat septic shock.
Modulation of the inflammatory response
Modulation of inflammation is an important strategy when
considering microvascular resuscitation. As discussed earlier,
the endothelium is actively involved in the systemic inflam-
matory response of sepsis and plays a key role in normal
microvascular regulation, in interactions with potentially
detrimental circulating leukocytes, and as the origin of a
tissue-based inflammatory response that ultimately leads to
organ dysfunction. Corticosteroid therapy represents a non-
specific approach to modulation of the systemic inflammatory
response, and has important anti-inflammatory effects on the
endothelium. Annane and colleagues found that more than
half of all patients with septic shock had an inadequate
adrenal response to adrenocorticotrophic hormone [38].
These patients responded well to low-dose hydrocortisone
(50 mg administered intravenously every 6 hours), and their
mortality decreased from 63% to 51%. However, indis-
criminant steroid use is not benign, and previous studies have
shown that high-dose corticosteroid therapy in septic shock
increases mortality [38]. Annane and colleagues demon-
strated that adrenocorticotrophic hormone responders had
reduced survival when treated with steroids [38].
Anticytokine therapy is an alternative approach to modulation
of the systemic inflammatory response, with subsequent
endothelial effects. While a large number of anticytokine
therapies have failed or have shown only marginal success in
phase III randomized, controlled trials, several recent meta-
analyses indicate that this strategy may be successful [39].
When the most severely ill patients are considered, these
anticytokine therapies have been uniformly successful in
decreasing mortality and measures of organ dysfunction [39].
Patient selection is critically important in ensuring that these
promising new therapies are properly implemented. Those
patients at high risk of an adverse outcome constitute the
target population.
Targeting the endothelium
The microcirculation in septic patients can also be
resuscitated by specifically targeting the endothelium using a
strategy that reduces inflammation and coagulation while
increasing fibrinolysis. This has led to the first successful
phase III randomized, controlled trial in a severe sepsis
patient population using exogenous activated protein C
(APC) to treat the uncontrolled cascade of inflammation,
coagulation, and impaired fibrinolysis that occurs [40].
Exogenous APC has specificity for key steps in the
inflammatory response and coagulation cascade that occurs
at or near the endothelial surface [41,42]. Through specific
anti-inflammatory effects, or as a result of its combined
actions at the endothelial cell luminal surface, exogenous
APC decreases organ dysfunction and improves survival in
patients with severe sepsis [6]. This provides further
evidence that the endothelium and, by inference, the
microvasculature play a key role in the pathogenesis and
outcome from sepsis.
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Conclusions
There are many data to show that microvascular dysfunction
contributes to higher mortality rates in sepsis. Impaired micro-
vascular blood flow in sepsis is caused by an alteration in
endothelial function and signaling, leading to some capillary
beds having reduced or even stopped blood flow, whilst
others have increased blood flow beyond their metabolic
demand. This heterogeneity in microvascular perfusion leads
to some areas of tissue receiving less oxygen than they
require, and results in regional hypoxia. The septic alterations
in endothelial signaling also result in an inflammatory
response which, in combination with hypoxia, can lead to
impaired organ function that has a major correlation with
mortality in sepsis.
A major therapeutic goal of treating sepsis is therefore to
restore normal microvascular function. Some animal studies
have shown that volume resuscitation can be effective in
restoring microvascular function; however, clinical studies
suggest that, in humans, this strategy is not enough. A
combinational strategy involving volume resuscitation,
vasopressors, and use of transfused red blood cells and/or
inotropic agents has been shown to improve survival. In
addition, mediation of inflammation is important, and studies
have shown that corticosteroids and anticytokine therapy
might be useful. Finally, therapies that specifically target the
endothelium might be able to reduce inflammation and
coagulation whilst increasing fibrinolysis. Studies of
exogenous APC have shown that this agent is successful in
reducing mortality in severe sepsis patients.
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